The Enbridge Ride to Conquer Cancer, now in its 8 th year as Quebec's largest cycling fundraiser, showcases the tremendous value and power of the enduring partnerships that the JGH Foundation enjoys with deeply committed corporate citizens such as Lundbeck Canada. Lundbeck Canada is a subsidiary of H. Lundbeck A/S, an international research-based pharmaceutical company focused on brain diseases and oncology that is celebrating its 100th year of existence. Based in Montreal, Lundbeck Canada has been active in the Canadian pharmaceutical industry for two decades now, marketing products for the treatment of depression, anxiety, Alzheimer's disease, schizophrenia, bipolar disorders, chronic lymphocytic leukemia, non-Hodgkin lymphoma, and acute promyelocytic leukemia.
Lundbeck Canada has participated in the Enbridge Ride to Conquer Cancer for the past five years, and was also a sponsor of the JGH Foundation's 1 st Annual Mindstrong Fitness Event (benefiting mental health services for youth) last year. This year, the company decided to step up its commitment in support of life-saving cancer research, treatment and care programs at the Jewish General Hospital and other cancer centres across the province by fielding a team of 10 cyclists and making their largest financial contribution to the Ride to-date.
"The main reason why we got involved in the Ride to Conquer Cancer is to help give hope to cancer patients and their loved ones, and let them know they are not alone in this fight," emphasizes Marcel Chenard, Head of Oncology Business Unit at Lundbeck Canada. "We take things for granted in life and we all know people who have been affected by this terrible disease. Riding over 200 kilometres over 2 days and raising money for this great cause is nothing compared to what people have to go through when they are diagnosed with cancer."
"By partnering with an innovative centre such as the Segal Cancer Centre, which is ahead of the game and the best in their class, we felt we could make the biggest impact," adds Mr. Chenard. "Our employees are committed to supporting this important initiative and we intend to keep riding for cancer in an effort to challenge the status quo, because Quebecers and Canadians living with cancer deserve better."
"Lundbeck Canada is a valued partner in the fight against cancer, and is setting an example for all corporations through their determination to make a difference by raising funds for research that will lead to better treatments and outcomes for patients," concurs JGH Foundation President and CEO, Myer Bick. "We are committed to providing opportunities like the Ride to Conquer Cancer for local and national corporations to play an important role in ensuring the continued health and well-being of our community."